Nath Bio-Genes (India) Limited (NSE:NATHBIOGEN)
143.84
+0.60 (0.42%)
At close: Mar 6, 2026
Revenue by Segment
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Revenue by Geography
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Source: S&P Global Market Intelligence.